HR+/HER2- Breast Cancer Treatment Guide 2025: Evidence-Based Clinical Decision Support for Optimal Patient Care | TAILORx, RxPONDER & monarchE Trials

Comprehensive clinical decision guide for HR+/HER2- early breast cancer treatment. Evidence-based recommendations across all scenarios. Updated March 2025 with latest trial data.